|
gptkbp:instanceOf
|
opioid
|
|
gptkbp:affiliatedWith
|
gptkb:phenylpiperidine
|
|
gptkbp:alsoKnownAs
|
gptkb:Demerol
pethidine
|
|
gptkbp:ATCCode
|
N02AB02
|
|
gptkbp:CASNumber
|
57-42-1
|
|
gptkbp:cause
|
addiction
tolerance
dependence
|
|
gptkbp:chemicalFormula
|
C15H21NO2
|
|
gptkbp:contraindication
|
MAOI use
severe respiratory insufficiency
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:discoveredBy
|
gptkb:Otto_Eisleb
|
|
gptkbp:discoveredIn
|
1939
|
|
gptkbp:eliminationHalfLife
|
2.5–4 hours
|
|
gptkbp:excretion
|
urine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
meperidine
|
|
gptkbp:KEGGID
|
D08144
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
1943
|
|
gptkbp:MeSH_ID
|
D008575
|
|
gptkbp:metabolism
|
liver
normeperidine
|
|
gptkbp:molecularWeight
|
247.33 g/mol
|
|
gptkbp:origin
|
gptkb:Germany
|
|
gptkbp:overdoseSymptoms
|
death
coma
respiratory depression
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
65–75%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1533
4058
DB00454
|
|
gptkbp:riskFactor
|
gptkb:serotonin_syndrome
seizures
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
subcutaneous
intravenous
|
|
gptkbp:sideEffect
|
nausea
constipation
dizziness
drowsiness
respiratory depression
|
|
gptkbp:UNII
|
UY443GR29W
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:usedIn
|
obstetrics
anesthesia
|
|
gptkbp:bfsParent
|
gptkb:monoamine_oxidase_inhibitors
gptkb:MAO_inhibitors
|
|
gptkbp:bfsLayer
|
6
|